80 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34992683 | Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells. | 2022 Feb | 5 |
2 | 35477477 | High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer. | 2022 Apr 27 | 1 |
3 | 33156701 | lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway. | 2021 Mar | 1 |
4 | 34360846 | Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells. | 2021 Jul 28 | 1 |
5 | 34749510 | Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer. | 2021 Nov | 1 |
6 | 32401925 | Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway. | 2020 | 2 |
7 | 32447047 | Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling. | 2020 Oct | 1 |
8 | 32547883 | Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways. | 2020 | 2 |
9 | 32594651 | Paclitaxel induces apoptosis through the TAK1-JNK activation pathway. | 2020 Aug | 1 |
10 | 32848392 | CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. | 2020 | 1 |
11 | 33087151 | Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway. | 2020 Oct 21 | 1 |
12 | 31660072 | CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. | 2019 | 2 |
13 | 28771725 | TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells. | 2018 Mar | 6 |
14 | 29567488 | Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells. | 2018 Jun | 2 |
15 | 29643394 | Author Correction: Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation. | 2018 Apr 12 | 1 |
16 | 30355931 | Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis. | 2018 | 4 |
17 | 30505814 | Naringin sensitizes human prostate cancer cells to paclitaxel therapy. | 2018 Dec | 1 |
18 | 28260091 | Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling. | 2017 Apr | 7 |
19 | 28440494 | Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer. | 2017 Jun | 2 |
20 | 28541685 | Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo. | 2017 Jun 22 | 1 |
21 | 26531258 | Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes. | 2016 Jan | 2 |
22 | 26596839 | Increased expression of MyD88 and association with paclitaxel resistance in breast cancer. | 2016 May | 1 |
23 | 26842845 | Profilin potentiates chemotherapeutic agents mediated cell death via suppression of NF-κB and upregulation of p53. | 2016 Apr | 1 |
24 | 25499080 | Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. | 2015 Feb 28 | 1 |
25 | 25681684 | Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. | 2015 Apr | 6 |
26 | 25791937 | Enhanced cell growth inhibition by thiacremonone in paclitaxel-treated lung cancer cells. | 2015 Jul | 1 |
27 | 26108226 | Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells. | 2015 | 2 |
28 | 26463651 | Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone. | 2015 Nov | 7 |
29 | 26502701 | INHIBITOR OF THE TRANSCRIPTION FACTOR NF-κB, DHMEQ, ENHANCES THE EFFECT OF PACLITAXEL ON CELLS OF ANAPLASTIC THYROID CARCINOMA IN VITRO AND IN VIVO. | 2015 May-Jun | 6 |
30 | 24462773 | CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells. | 2014 May | 2 |
31 | 24520227 | Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. | 2014 Jan | 2 |
32 | 24566868 | RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance. | 2014 Apr 15 | 3 |
33 | 25230791 | Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines. | 2014 Dec | 2 |
34 | 25550688 | Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells. | 2014 | 3 |
35 | 23380587 | Hypertonic stress promotes autophagy and microtubule-dependent autophagosomal clusters. | 2013 Apr | 1 |
36 | 23500524 | ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel. | 2013 Jun | 1 |
37 | 23708960 | CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells. | 2013 Oct | 1 |
38 | 22754361 | Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway. | 2012 | 2 |
39 | 22993037 | Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo. | 2012 Dec | 2 |
40 | 23027625 | Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway. | 2012 Dec | 3 |
41 | 23155247 | Desensitization of NFκB for overcoming chemoresistance of pancreatic cancer cells to TNF-α or paclitaxel. | 2012 Nov | 2 |
42 | 23170132 | Effect of NF-κB inhibitors on the chemotherapy-induced apoptosis of the colon cancer cell line HT-29. | 2012 Oct | 1 |
43 | 20883815 | Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. | 2011 Mar | 8 |
44 | 21223991 | Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. | 2011 Apr | 1 |
45 | 21289336 | Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer. | 2011 Jan-Feb | 1 |
46 | 21844414 | The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-κB inhibition. | 2011 Aug | 7 |
47 | 19824995 | Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo. | 2010 Jan | 2 |
48 | 19908232 | Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid. | 2010 Jul 15 | 1 |
49 | 19278222 | Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. | 2009 May-Jun | 2 |
50 | 19461204 | The role of Bcl-xL and nuclear factor-kappaB in the effect of taxol on the viability of dendritic cells. | 2009 Jun | 2 |